| EMA number | EMEA/H/C/000732 |
| ATC code | J07BM01 |
| Authorisation | 19 September 2006 |
| Withdrawn | 18 February 2019 |
| Revision | 33 |
Silgard is a vaccine for use from the age of 9 years for the prevention of: premalignant genital lesions (cervical, vulvar and vaginal), premalignant anal lesions, cervical cancers and anal cancers causally related to certain oncogenic Human Papillomavirus (HPV) types; genital warts (condyloma acuminata) causally related to specific HPV types. See sections 4.4 and 5.1 for important information on the data that support this indication. The use of Silgard should be in accordance with official recommendations.